Related Experiment Video
Updated: Feb 20, 2026

09:39
Techniques for the Analysis of Extracellular Vesicles Using Flow Cytometry
Published on: March 17, 2015
24.0K
Analysis of Individual Extracellular Vesicles by Flow Cytometry
1Scintillon Institute, San Diego, CA, 92121, USA. jnolan@scintillon.org.
Methods in Molecular Biology (Clifton, N.J.)
|October 27, 2017
Summary
Extracellular vesicles (EVs) are key biomarkers and therapeutic targets. This study presents a fluorescence-triggered Vesicle Flow Cytometry (VFC) method for precise single-EV analysis, overcoming limitations of bulk methods.
Area of Science:
- Biotechnology
- Cell Biology
- Nanomedicine
Background:
- Extracellular vesicles (EVs) are crucial intercellular communicators found in biofluids.
- EVs are heterogeneous, posing challenges for bulk analysis methods.
- Single-particle analysis is preferred but hindered by EV size and low antigen abundance.
Purpose of the Study:
- To address limitations in current extracellular vesicle (EV) analysis.
- To introduce and validate a fluorescence-triggered Vesicle Flow Cytometry (VFC) approach.
- To enable quantitative single-EV measurements of number, size, and surface markers.
Main Methods:
- Development of vesicle-specific assays for flow cytometry.
- Implementation of fluorescence triggering for enhanced detection sensitivity.
- Establishment of control experiments to ensure data accuracy and reproducibility.
- Application of fluorescence calibration for inter-laboratory data comparability.
Main Results:
- Demonstrated the utility of fluorescence-triggered VFC for quantitative EV measurement.
- Highlighted critical considerations for EV flow cytometry: triggering, controls, and calibration.
- Provided a framework for reliable single-EV analysis.
Conclusions:
- Fluorescence-triggered VFC offers a robust method for single extracellular vesicle (EV) characterization.
- Careful experimental design, including appropriate controls and calibration, is essential for accurate EV quantification.
- This approach advances the potential of EVs as disease biomarkers and therapeutic targets.

